Authors: ARDAVANIS A SCORILAS A LOUKERI A GERAKINI F PISSAKAS G MISSITZIS I APOSTOLIKAS N YIOTIS I

Citation: A. Ardavanis et al., CATHEPSIN-D MAY HELP IN DISCRIMINATING NODE-NEGATIVE BREAST-CANCER PATIENTS AT RISK FOR LOCAL-REGIONAL RECURRENCE, Anticancer research, 18(4B), 1998, pp. 2885-2890

Authors: ARDAVANIS A GERAKINI F AMANATIDOU A SCORILAS A PATERAS C GAROUFALI A PISSAKAS G STRAVOLEMOS K APOSTOLIKAS N YIOTIS I

Citation: A. Ardavanis et al., RELATIONSHIPS BETWEEN CATHEPSIN-D, PS2 PROTEIN AND HORMONAL RECEPTORSIN BREAST-CANCER CYTOSOLS - INCONSISTENCY WITH THEIR ESTABLISHED PROGNOSTIC-SIGNIFICANCE, Anticancer research, 17(5A), 1997, pp. 3665-3669

Authors: ARDAVANIS A SCORILAS A AMANATIDOU A GERAKINI F MISSITZIS I GAROUFALI A PISSAKAS G PATERAS C APOSTOLIKAS N RIGATOS G YIOTIS I

Citation: A. Ardavanis et al., CATHEPSIN-D CONCENTRATION IN TUMOR CYTOSOLS IMPROVES THE ACCURACY OF PROGNOSTIC EVALUATION OF PRIMARY BREAST-CANCER, Anticancer research, 17(2B), 1997, pp. 1405-1409

Authors: SCORILAS A YOTIS J STRAVOLEMOS K GOURIOTIS D KERAMOPOULOS A AMPELA K TALIERI M TRANGAS T

Citation: A. Scorilas et al., C-ERBB-2 OVEREXPRESSION MAY BE USED AS AN INDEPENDENT PROGNOSTIC FACTOR FOR BREAST-CANCER PATIENTS, Anticancer research, 15(4), 1995, pp. 1543-1547

Authors: SCORILAS A YOTIS J GOURIOTIS D KERAMOPOULOS A AMPELA K TRANGAS T TALIERI M

Citation: A. Scorilas et al., CATHEPSIN-D AND C-ERB-B-2 HAVE AN ADDITIVE PROGNOSTIC VALUE FOR BREAST-CANCER PATIENTS, Anticancer research, 13(5C), 1993, pp. 1895-1900